<i>MYO1E</i>Mutations and Childhood Familial Focal Segmental Glomerulosclerosis
Caterina Mele(Mario Negri Institute for Pharmacological Research), Marina Noris(Mario Negri Institute for Pharmacological Research), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Fatih Özaltın(University of Michigan), Andrea Calabria(The San Raffaele Telethon Institute for Gene Therapy), Franz Schaefer(Heidelberg University), Roberta Donadelli(Mario Negri Institute for Pharmacological Research), Marina Morigi(Mario Negri Institute for Pharmacological Research), Rossella Piras(Mario Negri Institute for Pharmacological Research), Simona Buelli(Mario Negri Institute for Pharmacological Research), Paraskevas Iatropoulos(Mario Negri Institute for Pharmacological Research), Massimo Delledonne(University of Verona), Paola Cassis(Mario Negri Institute for Pharmacological Research), Edgar A. Otto(University of Michigan), Mira Krendel(SUNY Upstate Medical University), Sevinç Emre(NYU Langone Health), Fabìo Macciardi(University of Milan), Susanna Tomasoni(Mario Negri Institute for Pharmacological Research), Carmine Pecoraro(University of Milan), Serena Bettoni(Mario Negri Institute for Pharmacological Research), Maria Rosaria Capobianchi, Friedhelm Hildebrandt(Boston Children's Hospital), Ariela Benigni(Mario Negri Institute for Pharmacological Research), Ramona Maranta(Mario Negri Institute for Pharmacological Research), Isabella Abbate(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Tulin Ibsirlioglu(University of Michigan)
Cited by 251
Related Papers
Non-Transgenic Mouse Models of Kidney Disease
|The Nephron journals/Nephron journals|2016|1.9k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Ciliopathies
|New England Journal of Medicine|2011|1.4k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990